Navigation Links
Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results
Date:8/5/2008

t expenses, sales, marketing and distribution expenses, and general and administrative expenses, based on the nature of the work the Company's employees were assigned to perform, totaled RMB6.4 million (US$0.9 million) for the second quarter of 2008. The share-based compensation expenses for the second quarter of 2007 were RMB7.7 million. For the first six months of 2008, share-based compensation expenses totaled RMB13.4 million (US$2.0 million), a decrease of 7.5% from RMB14.5 million for the first six months of 2007.

Operating income was RMB98.1 million (US$14.3 million) for the second quarter of 2008, representing an increase of 73.9% as compared to RMB56.4 million for the corresponding period of 2007. For the first six months of 2008, operating income was RMB197.3 million (US$28.8 million), an increase of 51.3% as compared to RMB130.5 million in the corresponding period in 2007.

Income tax expense for the second quarter of 2008 totaled RMB18.1 million (US$2.6 million) compared to an income tax credit of RMB4.0 million for the corresponding period of 2007. For the first six months of 2008, income tax expense was RMB34.9 million (US$5.1 million) compared to an income tax credit of RMB2.5 million for the first six months of 2007. In addition to the overall increase in taxable income, the increased income tax expense in 2008 was primarily due to the expiration of tax holidays enjoyed by two PRC subsidiaries.

Net income was RMB95.2 million (US$13.9 million) for the second quarter of 2008, compared to RMB83.1 million in the corresponding period a year ago and representing growth of 14.5%. The Company's net margin (net income as a percentage of total revenue) was 21.8% for the second quarter of 2008 compared to 24.9% for the second quarter of 2007. For the first six months of 2008, net income was RMB207.3 million (US$30.2 million), an increase of 38.1% as compared to RMB150.1 million for the first six months of 2007. Net margin for the first six mo
'/>"/>

SOURCE Simcere Pharmaceutical Group
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Simcere Pharmaceutical Group Acquires a 51% Stake in Boda Pharmaceutical Co., Ltd.
2. Simcere Pharmaceutical Group Reports Third Quarter 2007 Results
3. Simcere Pharmaceutical Group to Announce Fourth Quarter 2007 Earnings on Tuesday, March 4, 2008
4. Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2007 Results
5. Simcere Pharmaceutical Group Announces Participation in Brean Murray Carret & Co.s Fourth Investor Tour of China
6. Simcere Pharmaceutical Group to Announce First Quarter 2008 Earnings on Tuesday, May 6, 2008
7. Simcere Pharmaceutical Group Acquires 70% Stake in Wuhu Zhong Ren Pharmaceutical Co. Ltd.
8. Simcere Pharmaceutical Group Announces SFDA Approval of First-to-Market Generic Biapenem Injection Anxin
9. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
10. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... 18, 2014 It is true ... role when building a successful brand or business ... website, has recently compared plenty of professional web ... ), Arvixe and iPage are the best VPS ... importance of web hosting. All-sized businesses or enterprises ...
(Date:9/18/2014)... TX (PRWEB) September 18, 2014 Finding ... challenging, leaving many dieters feeling that their weight loss ... is specially trained in the science of fast weight ... results without negative side effects. In fact, a recent ... clients lost an average of 20 pounds during the ...
(Date:9/18/2014)... Texas Physical Therapy Specialists (TexPTS) is ... Hispanic Physicians Association (HPA) Friends and Family Golf tournament ... , The tournament, which will take place at TopGolf ... student scholarships through three golf challenges, “Top Scramble”, “Top ... Equipment is provided at the event and there will ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 ... SM9541 MEMS low pressure sensor Series designed ... high accuracy. The unique gage and differential offering ... The 14-Bit resolution and 1% accuracy provide the ... stability per year provides the reliability and long-term ...
(Date:9/18/2014)... CA (September 18, 2014) Cardiovascular disease is the ... plays a major role in accelerating its progression. ... treatment to decrease cholesterol-carrying lipoproteins such as small ... A new study, out today in the ... that rosuvastatin may be more effective among prediabetic ...
Breaking Medicine News(10 mins):Health News:Best Cheap Hosting USA: GreenGeeks, Arvixe And iPage Are The Best Hosting Suppliers In 2014 2Health News:Diet Doc Discloses the Results of a Recent In-House Survey Revealing an Average Loss of 20 Pounds Per Month with Their No Carb Diet Plans 2Health News:Diet Doc Discloses the Results of a Recent In-House Survey Revealing an Average Loss of 20 Pounds Per Month with Their No Carb Diet Plans 3Health News:Texas Physical Therapy Specialists Sponsoring HPA Friends & Family Golf Tournament 2Health News:SMI Launches Digital MEMS Low Pressure Sensor 2
... By Kathleen Doheny HealthDay Reporter , MONDAY, ... have had breast cancer, a higher intake of soy may ... study of Chinese women suggests. The same link was ... soy intake, the study authors said. The study, while ...
... is an association between type 2 diabetes mellitus and ... to a new study in Gastroenterology , the ... In 2000, the prevalence of type 2 ... people are projected to have the disease by 2030. ...
... (DOD) has awarded a $5 million grant to The ... Cincinnati to further develop a "lab-on-a-chip" device used for ... of severe brain trauma calls for cutting-edge tools to ... days after an injury. Working through the Feinstein Institute, ...
... PALO ALTO, CA (OCTOBER 15, 2010) Terminal metastatic ... of all cancer deaths has now been effectively treated ... Genomic Systems, citing research published online in the Proceedings ... Research conducted by Robert J. Debs, M.D., senior scientist ...
... 18, 2010 Estimates of the prevalence of liver ... has non‐alcoholic fatty liver disease (NAFLD). NAFLD is now ... in the United States, a trend related to the ... progressive form of NAFLD, can lead to cirrhosis and ...
... 18, 2010 At the American College of ... Antonio, Texas, several studies of the effectiveness of ... diagnostic strategies such as capsule endoscopy (CE) and ... patients with inflammatory bowel disease (IBD) and avoiding ...
Cached Medicine News:Health News:Soy May Reduce Breast Cancer Recurrence: Study 2Health News:Soy May Reduce Breast Cancer Recurrence: Study 3Health News:Type 2 diabetes and insulin use are associated with colorectal cancer in men 2Health News:Feinstein Institute to share $5M US Department of Defense grant 2Health News:Genomic Systems announces 'moratorium on studying and treating terminal cancer has ended' 2Health News:Encouraging findings suggest new avenues for treating liver disease in overweight Americans 2Health News:Encouraging findings suggest new avenues for treating liver disease in overweight Americans 3Health News:Diagnostic techniques help IBD patients avoid ionizing radiation exposure 2Health News:Diagnostic techniques help IBD patients avoid ionizing radiation exposure 3Health News:Diagnostic techniques help IBD patients avoid ionizing radiation exposure 4
(Date:9/18/2014)... -- Just days before the government of Sierra ... spread of Ebola, World Vision will begin a massive delivery ... private donations. McKesson, the largest healthcare services company ... affiliate McKesson Medical-Surgical donated four million pairs of latex gloves ... Sierra Leone,s needs for the next five months* ...
(Date:9/18/2014)... VIEW, Calif. and CHESTERBROOK, Pa. ... (Nasdaq: VVUS ) and Auxilium Pharmaceuticals, Inc. ... U.S. Food and Drug Administration (FDA) has approved a supplemental ... is now the only FDA-approved erectile dysfunction (ED) medication indicated ... sexual activity. STENDRA is a prescription medication in ...
(Date:9/17/2014)... Sept. 17, 2014 /PRNewswire-iReach/ -- DeepResearchReports.com adds "2014 ... Industry" and "2014 Market Research Report on Global ... its store. Photo - http://photos.prnewswire.com/prnh/20140917/146748 ... on Global Methyl Methacrylate (MMA) Industry" is a ... China and Global Methyl Methacrylate (MMA) ...
Breaking Medicine Technology:World Vision, McKesson, Other Donors Prepare for Massive Shipment of Medical Supplies to Support Sierra Leone Health Workers 2World Vision, McKesson, Other Donors Prepare for Massive Shipment of Medical Supplies to Support Sierra Leone Health Workers 3World Vision, McKesson, Other Donors Prepare for Massive Shipment of Medical Supplies to Support Sierra Leone Health Workers 4VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 2VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 3VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 4VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 5VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 6VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 7VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 8VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 9Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 2Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 3Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 4Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 5
For children up to 4 years of age 11 mm internal diameter of the cornea part. Designed to work with argon/YAG Lasers....
... The HAAG-STREIT OM 900 Ophthalmometer uses ... the three requirements of Helmholtz: 1. The ... of the distance between the Ophthalmometer and ... are independent of the distance between the ...
Advanced Corneal Topography System with integrated Keratometer. Keratometric and topographic measurements all in one instrument....
The best combination with the Haag-Streit 900 Slitlamps. For examination of the entire fundus, the vitreous and the iridocorneal angle. For children up to 4 years of age. 11 mm internal diameter of t...
Medicine Products: